Vessel and Inflammation

  • Catherine Bernard
Part of the Basic Science for the Cardiologist book series (BASC, volume 1)


Research in vascular biology has progressed remarkably in the last decade, resulting in a better understanding of vascular cell responses to inflammatory stimuli. The role of vascular cells during inflammatory processes is critical, being both target and sources of various proinflammatory cytokines. The secondary mediators involved in the regulation of the complex interactions between vascular cells and blood cells include adhesion molecules, chemokines, metalloproteinases and growth factors.


Nitric Oxide Endothelial Cell Vascular Smooth Muscle Cell Vascular Cell Arterioscler Thromb Vasc Biol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986;78:1432–8.PubMedGoogle Scholar
  2. 2.
    Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am JPathol 1986;124:179–85.Google Scholar
  3. 3.
    Loppnow H, Libby P. Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. Lymphokine Res 1989;8:293–9.PubMedGoogle Scholar
  4. 4.
    Warner SJ, Auger KR, Libby P. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol 1987;139:1911–7.PubMedGoogle Scholar
  5. 5.
    Warner SJ, Auger KR, Libby P. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med 1987;165:1316–31.PubMedGoogle Scholar
  6. 6.
    Warner SJ, Libby P. Human vascular smooth muscle cells. Target and source of Tumor Necrosis Factor. J Immunol 1989;142:100–109.PubMedGoogle Scholar
  7. 7.
    Schonbeck U, Herzberg M, Petersen A, et al. Human vascular smooth muscle cells express interleukin-1 beta-converting enzyme (ICE), but inhibit processing of the interleukin-1 beta precursor by ICE. J. Exp. Med. 1997;185:1287–1294.PubMedGoogle Scholar
  8. 8.
    Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: From molecular level to the bedside. Immunol. Today 1997; 18:231–240.Google Scholar
  9. 9.
    Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 1998;101:1261–72.PubMedGoogle Scholar
  10. 10.
    Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18:428–32.PubMedGoogle Scholar
  11. 11.
    Vora M, Yssel H, Devries JE, Karasek MA. Antigen presentation by human dermal microvascular endothelial cells-immunoregulatory effect of IFN-gamma and IL-10. J. Immunol. 1994;152:5734–5741.PubMedGoogle Scholar
  12. 12.
    Introna M, Mantovani A. Early activation signals in endothelial cells. Stimulation by cytokines. Arterioscler Thromb Vasc Biol 1997;17:423–128.PubMedGoogle Scholar
  13. 13.
    Bradley JR, Thiru S, Pober JS. Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules. Am. J. Pathol. 1995;147:627–641.PubMedGoogle Scholar
  14. 14.
    Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997;100:2752–6.PubMedGoogle Scholar
  15. 15.
    Nathan C, Sporn M. Cytokines in context. J. Cell Biol. 1991;113:981–986.PubMedGoogle Scholar
  16. 16.
    Pugin J, Ulevitch RJ, Tobias PS. A critical role for monocytes and CD14 in endotoxin induced endothelial cell activation. J. Exp. Med. 1993;178:2193–2200.PubMedGoogle Scholar
  17. 17.
    Pugin J, Ulevitch RJ, Tobias PS. Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations. Journal of Inflammation 1995;45:49–55.PubMedGoogle Scholar
  18. 18.
    Sterpetti AV, Cucina A, Dangelo LS, Cardillo B, Cavallaro A. Shear stress modulates the proliferation rate, protein synthesis, and mitogenic activity of arterial smooth muscle cells. Surgery 1993;113:691–699.PubMedGoogle Scholar
  19. 19.
    Lee S, Felts KA, Parry GCN, Armacost LM, Cobb RR. Inhibition of 5-lipoxygenase blocks IL-1 beta-induced vascular adhesion molecule-1 gene expression in human endothelial cells. J. Immunol. 1997;158:3401–3407.PubMedGoogle Scholar
  20. 20.
    De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96:60–8.PubMedGoogle Scholar
  21. 21.
    Spiecker M, Peng HB, Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 1997;272:30969–74.PubMedGoogle Scholar
  22. 22.
    Pendurthi UR, Williams JT, Rao LV. Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17:940–6.PubMedGoogle Scholar
  23. 23.
    Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 1997;94:1931–6.PubMedGoogle Scholar
  24. 24.
    Karmann K, Min W, Fanslow WC, Pober JS. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J. Exp. Med. 1996; 184:173–182.PubMedGoogle Scholar
  25. 25.
    Schonbeck U, Mach F, Bonnefoy JY, Loppnow H, Flad HD, Libby P. Ligation of CD40 activates interleukin 1 beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1 beta. J. Biol. Chem. 1997;272:19569–19574.PubMedGoogle Scholar
  26. 26.
    Henn V, Slupsky JR, Gräfe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591–594.PubMedGoogle Scholar
  27. 27.
    Laman JD, de Smet BJGL, Schoeneveld A, van Meurs M. CD40-CD40L interactions in atheroclerosis. Immunol Today 1997; 18:272–277.PubMedGoogle Scholar
  28. 28.
    Palmer-Crocker RL, Hughes CWC, Pober JS. IL-4 and IL-13 activate the JAK2 tyrosine kinase and STAT 6 in cultured human vascular endothelial cells through a common pathway that does not involve the gc chain. J Clin Invest 1996;98:604–609.PubMedGoogle Scholar
  29. 29.
    Bernard C, Merval R, Lebret M, et al. Activation of human vascular smooth muscle cells by oncostatin M. Synergy with IL-1. Circ Res 1998:in press.Google Scholar
  30. 30.
    Hirota H, Yoshida K, Taga T, Kishimoto T. gp 130 signaling pathways: recent advances and implications for cardiovascular disease. Tr Cardiovasc Med 1996;6:109–115.Google Scholar
  31. 31.
    Parry GCN, Mackman N. NF-kB mediated transcription in human monocytic cells and endothelial cells. Trends Cardiovasc Med 1998;8:138–142.Google Scholar
  32. 32.
    Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Faseb J. 1995;9:899–909.PubMedGoogle Scholar
  33. 33.
    Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82–6.PubMedGoogle Scholar
  34. 34.
    Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79–82.PubMedGoogle Scholar
  35. 35.
    Marx N, Sukhova G, Murphy C, Libby P, Plutzky J. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol 1998;153:17–23.PubMedGoogle Scholar
  36. 36.
    Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPARa but not by PPARg activators. Nature 1998;393:790–793.PubMedGoogle Scholar
  37. 37.
    Yao LB, Pan JL, Setiadi H, Patel KD, Mcever RP. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J. Exp. Med. 1996; 184:81–92.PubMedGoogle Scholar
  38. 38.
    Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993;74:541–54.PubMedGoogle Scholar
  39. 39.
    Labow MA, Norton CR, Rumberger JM, et al. Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity 1994; 1:709–20.PubMedGoogle Scholar
  40. 40.
    Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995;146:1287–301.PubMedGoogle Scholar
  41. 41.
    Taub DD. Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev 1996, 7:355–76.PubMedGoogle Scholar
  42. 42.
    Wang JM, Shen W, Su S. Chemokines and their role in cardiovascular diseases. Trends Cardiovasc Med 1998;8:169–174.Google Scholar
  43. 43.
    Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436–445.PubMedGoogle Scholar
  44. 44.
    Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998;273:4282–7.PubMedGoogle Scholar
  45. 45.
    Hayes IM, Jordan NJ, Towers S, et al. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol 1998; 18:397–403.PubMedGoogle Scholar
  46. 46.
    Goebeler M, Yoshimura T, Toksoy A, Ritter U, Brocker EB, Gillitzer R. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol 1997; 108:445–51.PubMedGoogle Scholar
  47. 47.
    Tenaglia AN, A.J.B, Wilkins RG, et al. Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris. Am J Cardiol 1997;79:742–747.PubMedGoogle Scholar
  48. 48.
    Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998, 279:381–4.PubMedGoogle Scholar
  49. 49.
    Sgadari C, Angiolillo AL, Tosato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 1996;87:3877–3882.PubMedGoogle Scholar
  50. 50.
    Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894–7.PubMedGoogle Scholar
  51. 51.
    Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86–9.PubMedGoogle Scholar
  52. 52.
    Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. Faseb J 1998;12:1075–95.PubMedGoogle Scholar
  53. 53.
    Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes-A role for CD40 signaling in plaque rupture? Circ. Res. 1997;81:448–454.PubMedGoogle Scholar
  54. 54.
    Yang JH, Briggs WH, Libby P, Lee RT. Small mechanical strains selectively suppress matrix metalloproteinase 1 expression by human vascular smooth muscle cells. J Biol Chem 1998;273:6550–5.PubMedGoogle Scholar
  55. 55.
    Fabunmi RP, Sukhova GK, Sugiyama S, Libby P. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res 1998;83:270–8.PubMedGoogle Scholar
  56. 56.
    Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990, 70:427–451.PubMedGoogle Scholar
  57. 57.
    Cines DB, PoUak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527–3561.PubMedGoogle Scholar
  58. 58.
    Harlan JM, Harker LA, Reidy MA, Gajdusek CM, Schwartz SM, Striker GE. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 1983;48:269–74.PubMedGoogle Scholar
  59. 59.
    Young JS, Headrick JP, Berne RM. Endothelial-dependent and-independent responses in the thoracic aorta during endotoxic shock. Circ Shock 1991, 35:25–30.PubMedGoogle Scholar
  60. 60.
    Robert R, Chapelain B, Jean T, Néliat G. Interleukin-1 impairs both vascular contraction and relaxation in rabbit isolated aorta. Biochem Biophys Res Commun 1992; 182:733–739.PubMedGoogle Scholar
  61. 61.
    Kessler P, Bauersachs J, Busse R, Schini-Kerth VB. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler Thromb Vase Biol 1997;17:1746–55.Google Scholar
  62. 62.
    Gamble JR, Khewgoodall Y, Vadas MA. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 1993; 150:4494–4503.PubMedGoogle Scholar
  63. 63.
    Eppihimer MJ, Granger DN. Endothelial cell adhesion molecule expression in acutely inflamed tissues. In: Vinent JL, ed. Update in intensive care and emergency medicine. Berlin Heidelberg: Springer Verlag, 1997:53–62.Google Scholar
  64. 64.
    Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: An emerging paradigm in endothelial adhesion biology. J. Clin. Invest. 1997;99:1809–1813.PubMedGoogle Scholar
  65. 65.
    Nagel T, Resnick N, Atkinson WJ, Dewey CF, Gimbrone MA. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J. Clin. Invest. 1994;94:885–891.PubMedGoogle Scholar
  66. 66.
    Lucas R, Lou JN, Morel DR, Ricou B, Suter PM, Grau GE. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J. Leukocyte Biol. 1997;61:551–558.PubMedGoogle Scholar
  67. 67.
    Beasley D, Cohen R, Levinsky N. Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am J Physiol 1990;258:H1187–H1192.PubMedGoogle Scholar
  68. 68.
    Julou-Schaeffer G, Gray G, Fleming I, Schott C, Parrat J, Stoclet J. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259:H1038–H1043.PubMedGoogle Scholar
  69. 69.
    Auguet M, Lonchampt MO, Delaflotte S, Goulinschulz J, Chabrier PE, Braquet P. Induction of nitric oxide synthase by lipoteichoic acid from staphylococcus-aureus in vascular smooth muscle cells. Febs Lett. 1992;297:183–185.PubMedGoogle Scholar
  70. 70.
    McKenna TM. Recovery of vascular tissue contractile function during sustained endotoxin exposure. Am J Physiol 1992;263:H1628–H1631.PubMedGoogle Scholar
  71. 71.
    Beasley D, Cohen RA, Levinski NG. Interleukin 1 inhibits contraction of vascular smooth muscle. J Clin Invest 1989;83:331–335.PubMedGoogle Scholar
  72. 72.
    Beasley D, Schwartz JH, Brenner BM. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991;87(2):602–8.PubMedGoogle Scholar
  73. 73.
    Bernard C, Szekely B, Philip I, Wollman E, Payen D, Tedgui A. Activated macrophages depress the contractility of rabbit carotids via an L-arginine:nitric oxide dependent effector mechanism. Connection with amplified cytokine release. J. Clin. Invest. 1992;89:851–860.PubMedGoogle Scholar
  74. 74.
    Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990;275:87–90.PubMedGoogle Scholar
  75. 75.
    Fleming I, Julouschaeffer G, Gray GA, Parratt JR, Stoclet JC. Evidence that an 1-arginine/nitric oxide dependent elevation of tissue cyclic gmp content is involved in depression of vascular reactivity by endotoxin. Br. J. Pharmacol. 1991;103:1047–1052.PubMedGoogle Scholar
  76. 76.
    French JF, Lambert LE, Dage RC. Nitric oxide synthase inhibitors inhibit interleukin-1-beta-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Therap. 1991;259:260–264.Google Scholar
  77. 77.
    Thorintrescases N, Hamilton CA, Reid JL, et al. Inducible L-arginine nitric oxide pathway in human internal mammary artery and saphenous vein. Am. J. Physiol. Heart Circ. Physiol. 1995;37:H1122–H1132.Google Scholar
  78. 78.
    Berrazueta JR, Salas E, Amado JA, Devega MJS, Poveda JJ. Induction of nitric oxide synthase in human mammary arteries in vitro. Eur. J. Pharmacol. 1994;251:303–305.PubMedGoogle Scholar
  79. 79.
    Beasley D, McGuiggin M. Interleukin-1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J Exp Med 1994, 179:71–80.PubMedGoogle Scholar
  80. 80.
    Geng YJ, Petersson AS, Wennmalm A, Hansson GK. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp. Cell Res. 1994;214:418–428.PubMedGoogle Scholar
  81. 81.
    Geng Y, Hansson GK, Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 1992;71:1268–1276.PubMedGoogle Scholar
  82. 82.
    Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends in Pharmacol Sci1998;19:287–298.Google Scholar
  83. 83.
    Szabo C, Zingarelli B, Oconnor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA 1996;93:1753–1758.PubMedGoogle Scholar
  84. 84.
    Szabo C, Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997;1:373–85.PubMedGoogle Scholar
  85. 85.
    Schwartz SM, Bennett MR. Death by any other name. Am J Pathol 1995;147:229–234.PubMedGoogle Scholar
  86. 86.
    Majno G, Joris I. Apoptosis, oncosis, and necrosis. Am J Pathol 1995;146:3–15.PubMedGoogle Scholar
  87. 87.
    Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998, 82:1111–1129.PubMedGoogle Scholar
  88. 88.
    Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266–2274.PubMedGoogle Scholar
  89. 89.
    Bennett MR, Littlewood TD, Schwartz SM, Weissberg PL. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res 1997, 81:591–599.PubMedGoogle Scholar
  90. 90.
    Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102:136–44.PubMedGoogle Scholar
  91. 91.
    Hebert MJ, Gullans SR, Mackenzie HS, Brady HR. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1 beta-dependent paracrine loop. Am J Pathol 1998;152:523–32.PubMedGoogle Scholar
  92. 92.
    Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment. Nature Med. 1997;3:196–204.PubMedGoogle Scholar
  93. 93.
    Bhagat K, Collier J, Vallance P. Local venous responses tea endotoxin in humans. Circulation 1996;94:490–497.PubMedGoogle Scholar
  94. 94.
    Lefer AM, Tsao P, Aoki N, Palladino MA, Jr. Mediation of cardioprotection by transforming growth factor-beta. Science 1990, 249:61–4.PubMedGoogle Scholar
  95. 95.
    Gamble JR, Bradley S, Noack L, Vadas MA. TGF-beta and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 1995; 15:949–955.Google Scholar
  96. 96.
    Perrella MA, Patterson C, Tan L, et al. Suppression of interleukin-1 beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta 1 in vascular smooth muscle cells-Evidence for mechanisms other than NF-kappa B. J. Biol. Chem. 1996;271(23): 13776–13780.PubMedGoogle Scholar
  97. 97.
    Kitamura M, Suto T, Yokoo T, Shimizu F, Fine LG. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 1996;156(8):2964–2971.PubMedGoogle Scholar
  98. 98.
    Radomski MW, Vallance P, Whitley G, Foxwell N, Moneada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc. Res. 1993;27:1380–1382.PubMedGoogle Scholar
  99. 99.
    Peng HB, Rajavashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 1995;270:17050–17055.PubMedGoogle Scholar
  100. 100.
    Shin WS, Hong YH, Peng HB, Decaterina R, Libby P, Liao JK. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma The role of constitutive NF-kappa B activity. J. Biol. Chem. 1996;271:11317–11324.PubMedGoogle Scholar
  101. 101.
    Sampath R, Kukielka GL, Smith CW, Eskin SG, Mcintire LV. Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro. Ann. Biomed. Eng. 1995;23:247–256.PubMedGoogle Scholar
  102. 102.
    Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 1997;185:601–607.PubMedGoogle Scholar
  103. 103.
    Sata M, Perlman H, Muruve DA, et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA 1998;95:1213–1217.PubMedGoogle Scholar
  104. 104.
    Karsan A, Yee E, Kaushansky K, Harlan JM. Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human Al in cultured endothelial cells. Blood 1996;87:3089–3096.PubMedGoogle Scholar
  105. 105.
    Terry CM, Clikeman JA, Hoidal JR, Callahan KS. Effect of tumor necrosis factor-a and interleukin-1 a on heme oxygenase-1 expression in human endothelial cells. Am J Physiol 1998;274:H883–H891.PubMedGoogle Scholar
  106. 106.
    Brindle NPJ. Growth factors in endothelial regeneration. Cardiovasc. Res. 1993;27:1162–1172.PubMedGoogle Scholar
  107. 107.
    Hansson GK, Schwartz SM. Evidence for cell death in the vascular endothelium in vivo and in vitro. Am JPathol 1983; 112:278–86.Google Scholar
  108. 108.
    Hansson GK, Chao S, Schwartz SM, Reidy MA. Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol 1985; 121:123–7.PubMedGoogle Scholar
  109. 109.
    Reidy MA, Schwartz SM. Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium. Lab Invest 1983;48:25–34.PubMedGoogle Scholar
  110. 110.
    Stemerman MB, Spaet TH, Pitlick F, Cintron J, Lejnieks I, Tiell ML. Intimai healing. The pattern of reendothelialization and intimai thickening. Am J Pathol 1977;87:125–42.PubMedGoogle Scholar
  111. 111.
    Tsurumi Y, Murohara T, Krasinski K, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Med 1997;3:879–886.PubMedGoogle Scholar
  112. 112.
    Böhrer H, Qiu F, Zimmermann T, et al. Role of NFkB in the mortality of sepsis. J Clin Invest 1997;100:972–985.PubMedGoogle Scholar
  113. 113.
    Zhang Y, Deng Y, Wendt T, et al. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma. J Clin Invest 1996;97:2213–24.PubMedGoogle Scholar
  114. 114.
    Szabo C, Salzman AL, Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. Febs Lett. 1995;363:235–238.PubMedGoogle Scholar
  115. 115.
    Hibbs JB, Westenfelder C, Taintor R, et al. Evidence for cytokine-inducible nitric oxide synthesis from 1-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 1992;89:867–877.PubMedGoogle Scholar
  116. 116.
    Ochoa JB, Curti B, Peitzman AB, et al. Increased circulating nitrogen oxides after human tumor immunotherapy correlation with toxic hemodynamic changes. J. Nat. Cancer Inst. 1992, 84:864–867.PubMedGoogle Scholar
  117. 117.
    Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991;214:621–626.PubMedGoogle Scholar
  118. 118.
    Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia reperfusion injury. Shock 1996;6:79–88.PubMedGoogle Scholar
  119. 119.
    Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186:1831–1841.PubMedGoogle Scholar
  120. 120.
    Abe JI, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trands Cardiovasc Med 1998, 8:59–64.Google Scholar
  121. 121.
    Zwacka RM, Zhou W, Zhang Y, et al. Redox gene therapy for ischaemia/reperfusion injury of the liver reduces AP1 and NFkB activation. Nature Med 1998;4:698–704.PubMedGoogle Scholar
  122. 122.
    Pantoni L, Sarti C, Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol 1998;18(4):503–13.PubMedGoogle Scholar
  123. 123.
    Gross V, Leser HG, Heinisch A, Scholmerich J. Inflammatory mediators and cytokines new aspects of the pathophysiology and assessment of severity of acute pancreatitis. Hepatogastroenterology 1993; 40:522–530.PubMedGoogle Scholar
  124. 124.
    Bautista AP, Spolarics Z, Jaeschke H, Smith CW, Spitzer JJ. Monoclonal antibody against the CD18 adhesion molecule stimulates glucose uptake by the liver and hepatic nonparenchymal cells. Hepatology 1993;18:1026.Google Scholar
  125. 125.
    Varani J, Ward PA. Mechanisms of endothelial cell injury in acute inflammation. Shock 1994;2:311–319.PubMedGoogle Scholar
  126. 126.
    Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JE. CD4+ T-Lymphocytes mediates ischemia-reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997;100:279–289.PubMedGoogle Scholar
  127. 127.
    Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischaemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998;29:1020–1030.PubMedGoogle Scholar
  128. 128.
    Eliasson MJL, Sampei K, Mndir AS, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischaemia. Nature Med 1997;3:1089–1095.PubMedGoogle Scholar
  129. 129.
    Zingarelli B, Salzman AL, Szabo C. Gene disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ichaemia/reperfusion injury. Circ Res 1998;83:85–94.PubMedGoogle Scholar
  130. 130.
    Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005–2016.PubMedGoogle Scholar
  131. 131.
    Ikeda H, Suzuki Y, Suzuki M, et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 1998, 42:530–537.PubMedGoogle Scholar
  132. 132.
    Silverstein FS. Can inhibition of apoptosis rescue ischemic brain. J Clin Invest 1998;101:1809–1810.PubMedGoogle Scholar
  133. 133.
    Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994, 266:1865–1869.PubMedGoogle Scholar
  134. 134.
    Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med. 1995;1:1274–1278.PubMedGoogle Scholar
  135. 135.
    Nickoloff BJ, Foreman KE. Charting a new course through the chaos of KS (Kaposi’s sarcoma). Am J Pathol 1996;148:1323–9.PubMedGoogle Scholar
  136. 136.
    Albini, Soldi A, Giunciuglio R, et al. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Med. 1996;2:1371–1375.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Catherine Bernard
    • 1
  1. 1.Department of AnesthesiologyLariboisière HospiralParisFrance

Personalised recommendations